Atlas Trials

Prospective Cohort Study for the Real - Life Effectiveness Evaluation of GlycOpyrronium With IndacatERol Combination in the Management of COPD in Canada (POWER Study)

Clinical trial NCT02202616 · COMPLETED

Trial details

NCT number
NCT02202616
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Chronic Obstructive Pulmonary Disease
Start date
2014-08-27
Primary completion
2017-04-05
Enrollment
401

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.